Buyers widening their own doors: demand already secured, far-side receiving constraint now being cleared
The model's full reasoning — Q2 2017 call → NOWe need to determine if the transcript conveys the specific situation: demand already in hand, constraint on receiving side, counterparties working on clearing it, and business mostly ahead. Let's analyze the transcript. Key points: - Management discusses net inflows, pipeline, etc. - There is a mention of "unfunded pipeline of mandates" of $903 million. These are mandates that have been won but not yet funded. This could be demand already in hand, but the funding is pending. However, the constraint is not necessarily on the receiving side; it's about the mandates being unfunded. The transcript says "unfunded pipeline" - meaning the money hasn't been invested yet. But is that due to the counterparties' ability to receive? Possibly, but management doesn't explicitly say that the constraint is the counterparties' own capacity to absorb. They just say "unfunded pipeline" and "pending finals". That might be more about the process of finalizing, not necessarily a receiving-side constraint. - There is a discussion about Japan distribution cut. They mention that the distribution partner reduced the distribution rate, and they expect net outflows in the short term. That's not about receiving-side constraint. - They mention new product launches, like the low duration preferred fund, and that they are seeing inflows. That's demand already arriving. - They mention "sub-advised portfolios in Japan had net inflows" and "two new model delivery sub advisory mandates... have begun to fund, these assets are not included in our AUM." So those are new mandates that are funding, but they are not in AUM yet. That could be demand in hand, but the constraint? They don't describe a receiving-side constraint. - They talk about "we are also now beginning to benefit from our recent investments in new usage launches in Europe" and "we gained regulatory approval for our global preferred SICAV, which also received funding of $45 million from a Japanese institutional investor." That's demand already there.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| NC | NACCO Industries, Inc. | Q1 2024 | 2024-05-05 | C+ |
| LTRX | Lantronix, Inc. | Q3 2024 | 2024-04-29 | C |
| CTO | CTO Realty Growth, Inc. | Q2 2023 | 2023-07-28 | B |
| BXP | Boston Properties, Inc. | Q1 2022 | 2022-05-03 | A |
| EXP | Eagle Materials Inc. | Q3 2022 | 2022-01-27 | B |
| MKC | McCormick & Company, Incorporated | Q2 2018 | 2018-06-28 | C+ |
| BIIB | Biogen Inc. | Q2 2017 | 2017-07-25 | B |
| PDCO | Patterson Companies, Inc. | Q3 2017 | 2017-02-23 | C |
| ARAY | Accuray Incorporated | Q4 2016 | 2016-08-17 | B |
MKC · Q2 2018 → YESThe question is about whether management conveys that they already have secured business or demand, but the bottleneck is the counterparties' ability to receive, install, etc., and those counterpartie...**NO** The transcript describes a situation where McCormick has already won shelf-space changes and distribution improvements from retailers (customers have accepted the recommendations), but implementation is delayed due to retailers' own operational reset windows and competitor product sell-through. This is framed as a temporary, ongoing industry practice rather than a binding constraint being actively cleared right now to unlock a meaningfully larger volume of already-secured business. Management presents it as part of their category-management progress with runway ahead, not as counterparties clearing a receiving-side bottleneck that is already underway and will drive the bulk of the upside.
BIIB · Q2 2017 → YESThe question is about whether management conveys that they already have secured demand, but the bottleneck is the counterparties' ability to receive/install/etc., and those counterparties are already ...YES The transcript shows management conveying exactly this situation for SPINRAZA. Demand is already secured and arriving: “significant uptake in the U.S.” with “strong demand across patient types” and “roughly two third of patients treated to date having Type 2 or Type 3 SMA.” The binding constraint is on 60% of Type 2 patients who have had spinal surgery, creating intrathecal administration challenges on the receiving side.
BXP · Q1 2022 → YESThe question is about whether management conveys that they already have secured business or demand, but the bottleneck is the counterparties' ability to receive/install/etc., and those counterparties ...YES The transcript shows management conveying secured demand through signed leases totaling over 975,000 square feet on vacant space that have not yet commenced occupancy, plus an additional 1.3 million square feet in active negotiations and over 750,000 square feet in the development pipeline.